Dr Francisco Gomez Goytia, MD - Medicare Diagnostic Radiology in Bayamon, PR

Dr Francisco Gomez Goytia, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Bayamon, Puerto Rico. He went to University Central Del Caribe Escuela De Medicina and graduated in 1980 and has 44 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Centro Medico Del Turabo Inc, Dla Imaging Llc, Gobierno Municipal De Cayey, Migrant Health Center Western Region, Inc and his current practice location is 100 Ave Laurel, Bayamon, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 345-6666.

Dr Francisco Gomez Goytia is licensed to practice in Puerto Rico (license number 8418) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1407810849.

Contact Information

Dr Francisco Gomez Goytia, MD
100 Ave Laurel,
Bayamon, PR 00956-4816
(787) 345-6666
Not Available



Physician's Profile

Full NameDr Francisco Gomez Goytia
GenderMale
SpecialityDiagnostic Radiology
Experience44 Years
Location100 Ave Laurel, Bayamon, Puerto Rico
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Francisco Gomez Goytia attended and graduated from University Central Del Caribe Escuela De Medicina in 1980
  NPI Data:
  • NPI Number: 1407810849
  • Provider Enumeration Date: 04/13/2006
  • Last Update Date: 12/10/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 9739085994
  • Enrollment ID: I20050316000133

Medical Identifiers

Medical identifiers for Dr Francisco Gomez Goytia such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1407810849NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology 8418 (Puerto Rico)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Bella Vista HospitalMayaguez, PRHospital
Hosp Comunitario Buen SamaritanoAguadilla, PRHospital
Hospital San Carlos BorromeoMoca, PRHospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Francisco Gomez Goytia allows following entities to bill medicare on his behalf.
Entity NameMed Centro Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295727147
PECOS PAC ID: 5890692131
Enrollment ID: O20031216000213

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameMigrant Health Center Western Region, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609969286
PECOS PAC ID: 4183520810
Enrollment ID: O20040617001321

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameMed Centro Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295727147
PECOS PAC ID: 5890692131
Enrollment ID: O20051102000919

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameInstituto Medico Del Norte Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154309169
PECOS PAC ID: 5597728816
Enrollment ID: O20061116000444

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameRad One, Psc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073684817
PECOS PAC ID: 9133225071
Enrollment ID: O20070509000401

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameCentro Medico Del Turabo Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710107883
PECOS PAC ID: 9335051952
Enrollment ID: O20080212000105

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameGobierno Municipal De Cayey
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801800776
PECOS PAC ID: 8628073533
Enrollment ID: O20090225000417

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameCentro De Imagenes Sonograficas
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1396723490
PECOS PAC ID: 8921283771
Enrollment ID: O20110421000358

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Entity NameDla Imaging Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366890311
PECOS PAC ID: 4981986015
Enrollment ID: O20170124002548

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Francisco Gomez Goytia is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Francisco Gomez Goytia, MD
Po Box 370,
Caguas, PR 00726-0370

Ph: (787) 294-0527
Dr Francisco Gomez Goytia, MD
100 Ave Laurel,
Bayamon, PR 00956-4816

Ph: (787) 345-6666

News Archive

Weight loss surgery helps reverse respiratory issues in obese patients

Obesity is now considered a global health epidemic, affecting millions of people worldwide. In morbidly obese patients, the extra weight has taken a toll on their overall health, including predisposing them to cardiovascular disease, type 2 diabetes, certain cancers, and respiratory issues. However, breathing issues in obese people may be reversed and relieved, thanks to weight loss surgery.

IVD Technology to launch first annual Virtual Conference and Tradeshow

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, today announced the launch of its first annual Virtual Conference and Tradeshow to be held on September 28, 2010.

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

Read more News

› Verified 6 days ago


Radiology Doctors in Bayamon, PR

Dr. Robert Rivera,
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1815 Road # 2 Km 11.7, Ct Radiology Complex Bldg, Bayamon, PR 00959
Phone: 787-780-9069    Fax: 787-780-2121
Dr. Pedro E Diaz Ortiz,
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Gallardo Towers, 201, Bayamon, PR 00961
Phone: 787-787-8029    Fax: 787-787-8029
Francisco Jose Orobitg Brenes, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Ct Radiology Complex, 1815 Carr 2, Bayamon, PR 00959
Phone: 787-780-9069    Fax: 787-778-4938
Dr. Carlos Balsalobre Alonso, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1815 Road No 2 Km 11.7, Ct Radiology Complex, Bayamon, PR 00959
Phone: 787-780-9069    Fax: 787-780-2121
Dr. Alberto Cerra Franco, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Ext. Hnas Davila. Marginal Pr #2. Esq 3b, Edificio 1955. Suite G1, Bayamon, PR 00959
Phone: 787-966-7500    
Rafael Andres Vicens Rodriguez, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1710 Carr 2 # Int167, Condominio Gallardo Towers Suite 101, Bayamon, PR 00961
Phone: 787-785-8034    Fax: 787-787-8029
Dr. Luisa Vanessa Marcial, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Ext. Hnas Davila Marginal Carr. Pr #2, Edificio 1955 Suite G-1, Bayamon, PR 00959
Phone: 787-966-7500    Fax: 787-966-7505

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.